Renal Cell Carcinoma

The highest vs lowest quartile of vitamin D binding protein was associated with 4.1-fold increased odds of renal cell carcinoma in adjusted analyses.

Microwave ablation for cT1b renal cell carcinoma has outcomes that compare favorably with partial and radical nephrectomy, a study found.

The method could more accurately classify patients with clear cell disease.

Following nephrectomy for renal cell carcinoma with lymph node involvement, patients have a 5-year survival rate of only 28%, a new study found.

Updated follow-up of patients in the KEYNOTE-427 trial showed that first-line pembrolizumab for advanced clear cell renal cell carcinoma exerts favorable antitumor activity after a median 23 months of follow-up.

Unmarried vs married men have lower rates of receiving cytoreductive nephrectomy, metastasectomy, and systemic therapy use, and unmarried vs married women have lower rates of cytoreductive nephrecotomy and systemic therapy use, a study found.

Superiority of the regimen was shown in intermediate- and poor-risk groups, as well as in intention-to-treat populations.

A retrospective study compared older patients with mRCC with younger ones to determine if age and potential comorbidities is a barrier to clinical trial participation.